Squarepoint Ops LLC Axsome Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

  • $96.1 Billion
  • Q3 2025

A detailed history of Squarepoint Ops LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 155,000 shares of AXSM stock, worth $21.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
155,000
Previous 163,000 4.91%
Holding current value
$21.7 Million
Previous $17 Million 10.63%
% of portfolio
0.02%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$100.39 - $129.29 $803,120 - $1.03 Million
-8,000 Reduced 4.91%
155,000 $18.8 Million
Q2 2025

Aug 27, 2025
BUY
$95.65 - $116.49 $2.05 Million - $2.49 Million
21,403 Added 15.12%
163,000 $17 Million
Q2 2025

Aug 14, 2025
BUY
$95.65 - $116.49 $2.05 Million - $2.49 Million
21,403 Added 15.12%
163,000 $17 Million
Q1 2025

Aug 27, 2025
SELL
$80.05 - $137.75 $1.71 Million - $2.95 Million
-21,403 Reduced 13.13%
141,597 $16.5 Million
Q1 2025

May 15, 2025
BUY
$80.05 - $137.75 $4.18 Million - $7.19 Million
52,167 Added 58.33%
141,597 $16.5 Million
Q4 2024

Feb 14, 2025
BUY
$83.08 - $100.49 $7.43 Million - $8.99 Million
89,430 New
89,430 $7.57 Million
Q4 2023

Feb 14, 2024
BUY
$57.42 - $83.61 $146,421 - $213,205
2,550 New
2,550 $202,000
Q4 2022

Feb 14, 2023
SELL
$39.94 - $79.72 $3.51 Million - $7.01 Million
-87,977 Reduced 66.35%
44,616 $3.44 Million
Q3 2022

Nov 14, 2022
BUY
$36.06 - $69.85 $4.48 Million - $8.68 Million
124,202 Added 1480.18%
132,593 $5.92 Million
Q2 2022

Aug 15, 2022
BUY
$21.74 - $46.75 $182,420 - $392,279
8,391 New
8,391 $321,000
Q4 2021

Feb 14, 2022
SELL
$30.7 - $43.36 $329,411 - $465,252
-10,730 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$19.91 - $68.26 $224,445 - $769,494
-11,273 Reduced 51.23%
10,730 $354,000
Q2 2021

Aug 16, 2021
BUY
$50.63 - $73.5 $479,668 - $696,339
9,474 Added 75.62%
22,003 $1.48 Million
Q1 2021

May 17, 2021
BUY
$55.91 - $81.44 $700,496 - $1.02 Million
12,529 New
12,529 $709,000
Q2 2020

Aug 14, 2020
SELL
$49.87 - $98.69 $909,329 - $1.8 Million
-18,234 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$41.2 - $101.31 $327,004 - $804,097
7,937 Added 77.08%
18,234 $1.07 Million
Q4 2019

Feb 14, 2020
BUY
$16.71 - $106.24 $172,062 - $1.09 Million
10,297 New
10,297 $1.06 Million
Q3 2019

Nov 14, 2019
SELL
$20.24 - $29.16 $763,169 - $1.1 Million
-37,706 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$13.46 - $25.75 $507,522 - $970,929
37,706 New
37,706 $971,000
Q1 2018

May 15, 2018
SELL
$2.35 - $5.6 $73,790 - $175,840
-31,400 Closed
0 $0
Q4 2017

Feb 14, 2018
SELL
$4.45 - $6.2 $9,790 - $13,640
-2,200 Reduced 6.55%
31,400 $176,000
Q3 2017

Nov 14, 2017
BUY
$4.65 - $6.1 $156,240 - $204,960
33,600
33,600 $186,000

Others Institutions Holding AXSM

# of Institutions
414
Shares Held
36.8M
Call Options Held
752K
Put Options Held
567K
View Full List

About Axsome Therapeutics, Inc.

AXSM Quotes by TradingView
  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $5.99B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email